Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  cancer stemness kinase inhibitor BBI503
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBIHCC-103, NCI-2014-02447, BBI608-503-103HCC, NCT02279719
A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: BBI503-205GYN-M, NCI-2015-01020, BBI503-205GOV-M, NCT02432690
A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI401-101, NCI-2015-02290, NCT02432326
Start Over